ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 628301 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 628301; 2) Community: the network communities that were significantly associated with the response to NSC 628301; 3) Molecule: the relationships between components within communities and NSC 628301; 4) MDR: the compounds that were significantly associated with the NSC 628301.

NSC Compound Enrichment Correlation
NSC 719660 1-O-Octadecyl-[(2.fwdarw.5')-3'-C-ethinyl-cytidylyl]-rac-glycerylyl-(3.fwdarw.5')-3'-azido-3'-deoxythymidine 0.00118765873091046 0.27204006
NSC 95779 Null 0.00118765873091046 0.45197367
NSC 638645 Null 0.00126165886744893 0.4858512
NSC 664404 - 0.00126165886744893 0.30499547
NSC 692308 Null 0.00126165886744893 0.43121525
NSC 716970 1H-Indole-2-carboxamide, N-[4-amino-1-(2-chloroethyl)-2-naphthalenyl]- 5,6,7-trimethoxy- 0.00126165886744893 0.18311319
NSC 618654 Null 0.00126165886744894 0.31418411
NSC 634035 4-amino-3-iodo-1-(.beta.-D-ribofuranosyl)pyrrolo[2,3-d] pyridazin-7-one 0.00134950525162028 0.39886822
NSC 645317 Sanguilutine pseudobase 0.00134950525162028 0.4748476
NSC 679002 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl]-, diethyl ester, cis- 0.00134950525162028 0.30823357
Total:105  Current:7    [First] [Prev] [Next] [Last]